Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AtaiBeckley Inc. - Common Stock
(NQ:
ATAI
)
4.390
+0.060 (+1.39%)
Streaming Delayed Price
Updated: 11:55 AM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AtaiBeckley Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
30
31
Next >
Atai Advances R-Ketamine Through Phase 1 Bridging Study, Update And Near-Term Expectations
↗
April 14, 2023
Clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) announced the dosing of the first subject in majority-owned subsidiary Perception Neuroscience’s Phase 1 intravenous-to-subcutaneous
Via
Benzinga
ATAI Life Sciences, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
April 14, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 13, 2023
↗
April 13, 2023
Via
Benzinga
atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
April 13, 2023
From
atai Life Sciences
Via
GlobeNewswire
Why Atai Life Sciences Stock Stormed Higher This Week
↗
March 31, 2023
The biotech's strong financial position may be attracting bargain buyers right now.
Via
The Motley Fool
Expert Ratings for ATAI Life Sciences
↗
March 27, 2023
Via
Benzinga
ATAI Life Sciences Earnings Perspective: Return On Capital Employed
↗
March 27, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 12, 2023
↗
April 12, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 11, 2023
↗
April 11, 2023
Via
Benzinga
Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More
↗
April 11, 2023
MDMA Therapy For PTSD Nearing Legalization In U.S. And Worldwide, MAPS Releases Promising Data
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 10, 2023
↗
April 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 7, 2023
↗
April 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 6, 2023
↗
April 06, 2023
Via
Benzinga
Compass Pathways, GH Research Among Top Psychedelic Movers Of Today
↗
April 05, 2023
Via
Benzinga
"Rags-To-Riches" Portfolio Down 8.6% In March; Now -3.9% YTD
↗
April 05, 2023
The
Via
Talk Markets
Psychedelic Stock Gainers And Losers From April 4, 2023
↗
April 04, 2023
Via
Benzinga
Butterfly Network, APE Preferred Shares And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
↗
April 04, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
↗
April 03, 2023
Via
Benzinga
Largest Psychedelic Stocks -3.4% In March
↗
April 02, 2023
The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From March 31, 2023
↗
March 31, 2023
Via
Benzinga
Why Shares of Atai Life Sciences Rose Friday
↗
March 31, 2023
The company's co-founder and chairman increased his position and explained why.
Via
The Motley Fool
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
↗
March 30, 2023
Via
Benzinga
IntelGenx's Q4 And Full-Year 2022 Financials, 'On The Cusp' Of Rapid Growth?
↗
March 30, 2023
Drug delivery company IntelGenx Technologies Corp. (OTCQB: IGXT)’s financial results for the three and twelve months ended December 31, 2022 show:
Via
Benzinga
$1.6M Bet On ATAI Life Sciences? Check Out These 4 Penny Stocks Insiders Are Buying
↗
March 30, 2023
The Dow Jones closed higher by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Why This Investor Is Buying More Than A Million Dollars Of A Biotech Company
↗
March 29, 2023
Christian Angermayer, the founder and Chairman of the Board of Apeiron Investment Group, is adding more than $1,000,000 in shares of ATAI Life Sciences NV (NASDAQ: ATAI).
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 29, 2023
↗
March 29, 2023
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 28, 2023
↗
March 28, 2023
Via
Benzinga
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
↗
March 27, 2023
Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 27, 2023
↗
March 27, 2023
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
